Timing of PCR and antibody testing in patients with COVID-19-associated dermatologic manifestations.

Freeman, Esther E; McMahon, Devon E; Hruza, George J; Lipoff, Jules B; French, Lars E; Fox, Lindy P; Fassett, Marlys S

Freeman, Esther E; McMahon, Devon E; Hruza, George J; Lipoff, Jules B; French, Lars E; Fox, Lindy P; Fassett, Marlys S.

Afiliação

Freeman EE; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston. Electronic address: efreeman@mgh.harvard.edu.
McMahon DE; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston.
Hruza GJ; Department of Dermatology, St. Louis University, Missouri.
Lipoff JB; Department of Dermatology, University of Pennsylvania, Philadelphia.
French LE; Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Germany.
Fox LP; Department of Dermatology, University of California-San Francisco.
Fassett MS; Department of Dermatology, University of California-San Francisco; Department of Immunology and Microbiology, University of California-San Francisco.

J Am Acad Dermatol ; 84(2): 505-507, 2021 02.

Article em En | MEDLINE | ID: mdl-32920037

Assuntos

Teste de Ácido Nucleico para COVID-19; COVID-19/complicações; COVID-19/diagnóstico; Dermatopatias/etiologia; Humanos; Fatores de Tempo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Teste de Ácido Nucleico para COVID-19 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google